Ellington Residential Mortgage REIT’s 3,000,000 common shares Offering

Vinson & Elkins advised Ellington Residential Mortgage REIT in its public offering of 3,000,000 common shares, which priced on May 10, 2017. Ellington Residential Mortgage REIT is a mortgage real estate investment trust that specializes in acquiring, investing in and managing residential mortgage- and real estate-related assets. The V&E team was led by partners Daniel […]

Fred’s and Alden Global Capital LLC’s Cooperation Agreement

Vinson & Elkins advised Fred’s, Inc. in connection with the Cooperation Agreement between Fred’s and Alden Global Capital LLC, the largest shareholder of Fred’s with approximately 24.4% of the shares. Fred’s Pharmacy is headquartered in Memphis, Tenn., and operates 601 pharmacy and general merchandise stores and three specialty pharmacy-only locations, including 14 franchised Fred’s Pharmacy […]

Millar Western Forest Products’ Recapitalization

Paul, Weiss represented Millar Western Forest Products Ltd. (Millar Western) in the completion of a recapitalization by way of a court approved plan of arrangement. As part of the arrangement Millar Western’s existing unsecured noteholders exchanged $210 million aggregate principal amount of 8.5% senior notes due 2021 for $131 million aggregate principal amount of 9.0% […]

Pivot Physical Therapy’s Acquisition of Tidewater Physical Therapy

Paul, Weiss represented Pivot Physical Therapy, a leading provider of physical therapy, sports medicine and aquatic therapy services, in its acquisition of Tidewater Physical Therapy, an outpatient physical therapy practice. Pivot is a portfolio company of Paul, Weiss client CI Capital Partners. Financial terms of the transaction were not disclosed. The Paul, Weiss team included […]

i2b2 Foundation’s Merger with The tranSMART Foundation

Choate Advises i2b2 Foundation in its Intent to Merge with The tranSMART Foundation The two leading open-source foundations (The tranSMART Foundation and the i2b2 Foundation) in the healthcare and translational research space are merging into a single foundation to advance the field of precision medicine. These organizations provide open-source software and databases representing more than […]

Tocagen’s $98 Million Initial Public Offering

Cooley advised Tocagen on its $97.8 million initial public offering of 9,775,000 shares of common stock. San Diego-based Tocagen, which trades on The NASDAQ Global Select Market as “TOCA,” is a clinical-stage, cancer-selective gene therapy company developing first-in-class, broadly applicable product candidates designed to activate a patient’s immune system against their own cancer. Cooley has […]

Athene Holding’s $1.3 Billion Secondary Offering

Fried Frank acted as counsel to the underwriters for Athene Holding’s secondary follow-on offering of 27.5 million shares of its common stock for an aggregate total amount of over US$1.3 billion. Goldman, Sachs & Co., Barclays, Citigroup and Wells Fargo Securities are acting as joint book runners of the offering and representatives of the underwriters. […]

ERYTECH’s €70.5 Million Private Placement

Cooley advised ERYTECH Pharma on a private placement of its ordinary shares to qualified investors in the US and Europe. Total gross proceeds to ERYTECH were approximately €70.5 million. ERYTECH, based in Lyon, France, with US headquarters in Cambridge, MA, is a clinical-stage biopharmaceutical company developing innovative therapies for rare forms of cancer and orphan […]

FibroGen’s $120 Million Shelf Takedown

Cooley advised FibroGen on its $120 million shelf takedown of 5,228,750 shares of common stock. FibroGen, which is headquartered in San Francisco and trades on The NASDAQ Global Select Market as “FGEN,” is a research-based biopharmaceutical company using its expertise in connective tissue growth factor and hypoxia-inducible factor biology to discover, develop and commercialize novel […]

SeatGeek’s $57 Million Round Financing

Cooley advised SeatGeek on its $57 million Series D financing round and concurrent acquisition of Israeli-based ticketing software company TopTix for $56 million. The acquisition will power the expansion of SeatGeek Open, SeatGeek’s primary ticketing platform that launched in 2016, which enables artists and teams to sell tickets directly within other apps and websites. TopTix […]